Haji Shojiro, Shiratsuchi Motoaki, Takamatsu Akiko, Tsuda Mariko, Muta Hiroki, Masuda Toru, Nakashima Yasuhiro, Ogawa Yoshihiro
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
Department of Hematology, Iizuka Hospital, Iizuka, 820-8505, Japan.
Int J Hematol. 2023 Mar;117(3):438-445. doi: 10.1007/s12185-022-03498-3. Epub 2022 Nov 27.
Hematopoietic stem cell transplantation (HSCT) is a useful tool for the treatment of hematologic malignancies. However, transplantation-related complications are the main cause of non-relapse mortality. Previous reports suggest that endothelial damage is related to early complications after HSCT. Non-invasive reactive hyperemia peripheral arterial tonometry (RH-PAT) was performed to evaluate endothelial function as a predictive marker for these complications.
The reactive hyperemia index (RHI) obtained from RH-PAT was evaluated before the conditioning regimen. The relationship between the RHI and the appearance of engraftment syndrome, thrombotic microangiopathy, and acute graft-versus-host disease (aGVHD) was assessed. Receiver operating characteristic curve analysis showed that an RHI value of 1.58 was the optimal cut-off for predicting transplantation-related complications.
In total, 49 patients (22 acute myelogenous leukemia, 7 acute lymphocytic leukemia, 6 myelodysplastic syndrome, 6 adult T-cell leukemia, 6 non-Hodgkin lymphoma, and 2 others) were enrolled; 34 had a normal RHI (≥ 1.59), and 15 had an abnormally low RHI (≤ 1.58). Thrombotic microangiopathy (20.2% vs 0.0%, P = 0.025) and aGVHD (80.0% vs 41.2%, P = 0.015) were significantly more frequent in patients with a low RHI.
Endothelial dysfunction assessed by RH-PAT before HSCT was able to predict transplantation-related complications.
造血干细胞移植(HSCT)是治疗血液系统恶性肿瘤的一种有效手段。然而,移植相关并发症是导致非复发死亡率的主要原因。既往报道提示,内皮损伤与HSCT后的早期并发症相关。采用非侵入性反应性充血外周动脉张力测定法(RH-PAT)评估内皮功能,作为这些并发症的预测指标。
在预处理方案前,对通过RH-PAT获得的反应性充血指数(RHI)进行评估。评估RHI与植入综合征、血栓性微血管病及急性移植物抗宿主病(aGVHD)发生情况之间的关系。受试者工作特征曲线分析显示,RHI值为1.58是预测移植相关并发症的最佳临界值。
共纳入49例患者(22例急性髓系白血病、7例急性淋巴细胞白血病、6例骨髓增生异常综合征、6例成人T细胞白血病、6例非霍奇金淋巴瘤及2例其他类型);34例患者RHI正常(≥1.59),15例患者RHI异常低(≤1.58)。RHI低的患者血栓性微血管病(20.2%对0.0%,P = 0.025)和aGVHD(80.0%对41.2%,P = 0.015)的发生率显著更高。
HSCT前通过RH-PAT评估的内皮功能障碍能够预测移植相关并发症。